Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Operating Expenses (2018 - 2026)

TELA Bio has reported Operating Expenses over the past 8 years, most recently at $20.4 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 4.23% year-over-year to $20.4 million; the TTM value through Dec 2025 reached $88.1 million, changed 0.1%, while the annual FY2025 figure was $88.1 million, 0.1% changed from the prior year.
  • Operating Expenses for Q4 2025 was $20.4 million at TELA Bio, down from $21.5 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $23.9 million in Q4 2023 and troughed at $10.7 million in Q1 2021.
  • A 5-year average of $18.7 million and a median of $20.0 million in 2024 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: soared 70.98% in 2021 and later dropped 18.1% in 2024.
  • Year by year, Operating Expenses stood at $13.3 million in 2021, then skyrocketed by 32.31% to $17.6 million in 2022, then surged by 35.69% to $23.9 million in 2023, then dropped by 18.1% to $19.6 million in 2024, then increased by 4.23% to $20.4 million in 2025.
  • Business Quant data shows Operating Expenses for TELA at $20.4 million in Q4 2025, $21.5 million in Q3 2025, and $23.2 million in Q2 2025.